114 related articles for article (PubMed ID: 9867528)
1. Enoxaparin in neurosurgical patients.
Connolly ES; Mocco J
N Engl J Med; 1998 Nov; 339(22):1639-40. PubMed ID: 9867528
[No Abstract] [Full Text] [Related]
2. Enoxaparin for the prevention of venous thromboembolism.
Calderon EJ; Varela JM; Gonzalez de la Puente MA
N Engl J Med; 2000 Jan; 342(2):136-7. PubMed ID: 10636758
[No Abstract] [Full Text] [Related]
3. Prevention of venous thromboembolism in the acute treatment phase after spinal cord injury: a randomized, multicenter trial comparing low-dose heparin plus intermittent pneumatic compression with enoxaparin.
Spinal Cord Injury Thromboprophylaxis Investigators
J Trauma; 2003 Jun; 54(6):1116-24; discussion 1125-6. PubMed ID: 12813332
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease.
Kleber FX; Witt C; Vogel G; Koppenhagen K; Schomaker U; Flosbach CW;
Am Heart J; 2003 Apr; 145(4):614-21. PubMed ID: 12679756
[TBL] [Abstract][Full Text] [Related]
5. Enoxaparin for the prevention of venous thromboembolism.
Sosis MB
N Engl J Med; 2000 Jan; 342(2):136; author reply 137. PubMed ID: 10636757
[No Abstract] [Full Text] [Related]
6. A safety analysis of thromboprophylaxis in acute medical illness.
Alikhan R; Cohen AT
Thromb Haemost; 2003 Mar; 89(3):590-1. PubMed ID: 12624645
[No Abstract] [Full Text] [Related]
7. [Evidence for thrombosis prophylaxis to high-risk patients].
Själander A; Jansson JH; Bergqvist D; Eriksson H; Svensson P
Lakartidningen; 2007 May 14-29; 104(20-21):1585-7. PubMed ID: 17564265
[No Abstract] [Full Text] [Related]
8. Current practice of thromboprophylaxis in the burn population: a survey study of 84 US burn centers.
Ferguson RE; Critchfield A; Leclaire A; Ajkay N; Vasconez HC
Burns; 2005 Dec; 31(8):964-6. PubMed ID: 16269216
[TBL] [Abstract][Full Text] [Related]
9. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
10. How should we define major bleeding events in thromboprophylaxis?
Bottaro FJ; Ceresetto JM
J Bone Joint Surg Am; 2010 Nov; 92(15):2617-8; author reply 2618-9. PubMed ID: 21048185
[No Abstract] [Full Text] [Related]
11. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
[TBL] [Abstract][Full Text] [Related]
12. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.
Samama MM; Cohen AT; Darmon JY; Desjardins L; Eldor A; Janbon C; Leizorovicz A; Nguyen H; Olsson CG; Turpie AG; Weisslinger N
N Engl J Med; 1999 Sep; 341(11):793-800. PubMed ID: 10477777
[TBL] [Abstract][Full Text] [Related]
13. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.
Agnelli G; Piovella F; Buoncristiani P; Severi P; Pini M; D'Angelo A; Beltrametti C; Damiani M; Andrioli GC; Pugliese R; Iorio A; Brambilla G
N Engl J Med; 1998 Jul; 339(2):80-5. PubMed ID: 9654538
[TBL] [Abstract][Full Text] [Related]
14. Enoxaparin versus unfractionated heparin in ST-elevation myocardial infarction.
Sleight P; Eikelboom JW; Bassand JP
N Engl J Med; 2006 Jun; 354(26):2830-1; author reply 2831-2. PubMed ID: 16810777
[No Abstract] [Full Text] [Related]
15. Prevention of venous thromboembolism in the rehabilitation phase after spinal cord injury: prophylaxis with low-dose heparin or enoxaparin.
Spinal Cord Injury Thromboprophylaxis Investigators
J Trauma; 2003 Jun; 54(6):1111-5. PubMed ID: 12813331
[TBL] [Abstract][Full Text] [Related]
16. A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement.
Turpie AG; Gallus AS; Hoek JA;
N Engl J Med; 2001 Mar; 344(9):619-25. PubMed ID: 11228275
[TBL] [Abstract][Full Text] [Related]
17. Differences in the safety profiles of two low-molecular-weight heparins.
Ofosu FA
Thromb Haemost; 2008 Jun; 99(6):989-90. PubMed ID: 18521496
[No Abstract] [Full Text] [Related]
18. Venous thromboembolism prophylaxis conversion in nonsurgical inpatients.
Carroll DN; Hudson EB
Ann Pharmacother; 2003 Sep; 37(9):1194-6. PubMed ID: 12921498
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis for thromboembolism in hospitalized medical patients.
Calderón-Gerstein W
N Engl J Med; 2007 Jul; 357(3):304-5; author reply 305-6. PubMed ID: 17634471
[No Abstract] [Full Text] [Related]
20. Enoxaparin in elective percutaneous coronary intervention.
Hamon M; Riddell JW
N Engl J Med; 2006 Dec; 355(26):2788-9; author reply 2790-1. PubMed ID: 17195309
[No Abstract] [Full Text] [Related]
[Next] [New Search]
